Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

MYC overexpression + IDH2 mutation

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

IDH2 mutation (70)

MYC rearrangement + BCL2 rearrangement (22)

MYC rearrangement + BCL6 rearrangement (9)

MYC rearrangement (7)

MYC rearrangement + BCL2 rearrangement + BCL6 rearrangement (6)

MYC mutation (5)

MYC translocation (4)

MYC translocation + BCL2 translocation (3)

IDH wild-type (3)

FLT3-ITD mutation + IDH2 mutation (2)

EGFR exon 19 deletion + ATM S1455fs*36 + MYC E62K (1)

MYC translocation + BCL6 translocation (1)

MYC translocation + BCL6 translocation + BCL2 translocation (1)

DNMT3A mutation + IDH mutation (1)

IDH1 R132C + PIK3CA E545K + IDH2 R172K (1)

IDH2 R140Q + NPM1 mutation (1)

IDH2 R140W + EGFR L858R (1)

IDH2 mutation + NRAS mutation (1)

IDH2 mutation + SRSF2 mutation (1)

IDH2 mutation + TP53 mutation (1)

IDH2 mutation + NPM1 mutation (1)

PIK3CA mutation + TTN mutation + IDH2 mutation (1)

TTN mutation + IDH2 mutation (1)

MYC rearrangement + BCL2 rearrangement+ BCL6 rearrangement (0)

IDH mutation + BRAF V600E (0)

IDH mutation + Chr del(1p) + Chr del(19q) (0)

IDH mutation + Chr del(1p) + Chr del(19q) + BRAF V600E (0)

IDH mutation + Chr del(1p) + Chr del(19q) + NTRK fusion (0)

IDH mutation + NTRK fusion (0)

IDH2 mutation (70)

MYC rearrangement + BCL2 rearrangement (22)

MYC rearrangement + BCL6 rearrangement (9)

MYC rearrangement (7)

MYC rearrangement + BCL2 rearrangement + BCL6 rearrangement (6)

MYC mutation (5)

MYC translocation (4)

MYC translocation + BCL2 translocation (3)

IDH wild-type (3)

FLT3-ITD mutation + IDH2 mutation (2)

EGFR exon 19 deletion + ATM S1455fs*36 + MYC E62K (1)

MYC translocation + BCL6 translocation (1)

MYC translocation + BCL6 translocation + BCL2 translocation (1)

DNMT3A mutation + IDH mutation (1)

IDH1 R132C + PIK3CA E545K + IDH2 R172K (1)

IDH2 R140Q + NPM1 mutation (1)

IDH2 R140W + EGFR L858R (1)

IDH2 mutation + NRAS mutation (1)

IDH2 mutation + SRSF2 mutation (1)

IDH2 mutation + TP53 mutation (1)

IDH2 mutation + NPM1 mutation (1)

PIK3CA mutation + TTN mutation + IDH2 mutation (1)

TTN mutation + IDH2 mutation (1)

MYC rearrangement + BCL2 rearrangement+ BCL6 rearrangement (0)

IDH mutation + BRAF V600E (0)

IDH mutation + Chr del(1p) + Chr del(19q) (0)

IDH mutation + Chr del(1p) + Chr del(19q) + BRAF V600E (0)

IDH mutation + Chr del(1p) + Chr del(19q) + NTRK fusion (0)

IDH mutation + NTRK fusion (0)

›

MYC overexpression + IDH2 mutation	Acute Myelogenous Leukemia	MYC overexpression + IDH2 mutation	Acute Myelogenous Leukemia	enasidenib Resistant: C3 – Early Trials enasidenib Resistant : C3	enasidenib Resistant: C3 – Early Trials enasidenib Resistant : C3
MYC overexpression + IDH2 mutation	Acute Myelogenous Leukemia	MYC overexpression + IDH2 mutation	Acute Myelogenous Leukemia	ivosidenib Resistant: C3 – Early Trials ivosidenib Resistant : C3	ivosidenib Resistant: C3 – Early Trials ivosidenib Resistant : C3